ArticleCancer chemotherapy and pharmacology2024
Predictive factors for first dose reduction and interruption of lenvatinib after beginning of the standard dose in Japanese patients with thyroid cancer.
Kazuma Fujita et al.PubMed ↗Publisher ↗
No numbers read from the abstract.